A new University of Hawaiʻi Cancer Center coordinated liver cancer clinical trial opened in Hawaiʻi combining two different immunotherapy medications to combat the aggressive disease. The Phase II clinical trial is only available in Hawaiʻi, a state with one of the...
Seven Compelling Stories Spotlight the Benefits of Clinical Trial Participation, Access to Life-Saving Medical Advances, and Optimal Lung Cancer Care and Treatment Options WASHINGTON, Nov. 14, 2019 /PRNewswire/ — LUNGevity, the nation’s leading lung...
Topline results expected before the end of Q1/2020 REHOVOT, Israel and NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) — Todos Medical Ltd. (TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of...
– Reflects company values and commitment to patients living with hypoparathyroidism – – Top-line data from expanded PaTH Forward Trial expected in first quarter of 2020 – – Company expects to exceed targeted enrollment of 40 subjects...
PDC-1421 high-dose data meets primary endpoint on MADRS scale in ITT clinical trial population PDC-1421 low-dose and PDC-1421 high-dose each proved safe, were well-tolerated, and had no serious adverse events associated with them in Phase II clinical trial Company is...
Email
Text